Related Experiment Video
Updated: Aug 5, 2026
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
"The role of red cell distribution width in inflammatory bowel disease evaluation: a comprehensive systematic review
Yasser Khalil1, Mohamed A Elhodhod2, Mohammed Barghash3
1Faculty of Medicine, Helwan University, Cairo, Egypt.
Background:
Inflammatory markers are routinely used in the evaluation of inflammatory bowel disease (IBD). Red blood cell distribution width (RDW) has previously been proposed as a potential biomarker in the evaluation of IBD. This meta-analysis and systematic review challenges the utility of RDW in IBD evaluation.
Methods:
We conducted a systematic review and meta-analysis following PRISMA guidelines. A search strategy was formulated based on Medical Subject Headings (MeSH) terms and other relevant medical terms. A comprehensive search of PubMed, Web of Science, and Scopus was performed up to 4th of September 2025. Data were extracted for identifying the role of RDW in IBD detection and its association with disease activity. Statistical analysis employed a random-effects model, with subgroup analysis performed according to different levels of disease activity.
Results:
RDW was significantly elevated in patients suffering from Crohn's disease (CD) (MD = 2.2, p < 0.001) and ulcerative colitis (UC) (MD = 1.36, p < 0.001) compared to healthy controls. Both diseases showed significantly higher RDW in active disease versus remission (CD: MD = 1.29, p < 0.001; UC: MD = 1.11%, p < 0.001). For differentiating active CD from remission, an RDW cut-off > 14% showed a sensitivity of 0.86 and specificity of 0.78 (AUC = 0.83). RDW levels were also significantly higher in active CD compared to active UC (MD = 0.59, p < 0.005).
Conclusion:
RDW levels were markedly increased in patients with IBD compared to healthy controls. Furthermore, RDW showed a consistent association with both disease activity and severity. Given its wide availability, low cost, and reliable diagnostic performance, RDW could represent a practical and valuable biomarker for evaluating inflammatory bowel disease.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction